Better Reimbursement, More Incentives Needed For Peds Device Development, Stakeholders Tell FDA

At a recent pediatric medical devices workshop at US FDA headquarters, the focus turned less to regulatory burdens and more to lacking reimbursement and financial incentives as barriers to bringing child-focused products to market.

MT1808_Pediatric Monitor_138153896_1200.jpg

More from Policy & Regulation

More from Medtech Insight